Celebrex and Bone development abnormal - a phase IV clinical study of FDA data

Summary:

Bone development abnormal is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 60+ old, also take Diflucan, and have High blood pressure.

The phase IV clinical study analyzes which people have Bone development abnormal when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Bone development abnormal?

Bone development abnormal is found to be associated with 76 drugs and 124 conditions by eHealthMe. Check the latest studies of Bone development abnormal.

On Jul, 13, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 15 people (0.01%) have Bone development abnormal.

Could Celebrex cause Bone development abnormal?

Among these 15 people:

What is the gender of people who have Bone development abnormal when taking Celebrex? *

female: 100 %
male: 0.0 %

What is the age of people who have Bone development abnormal when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Bone development abnormal? *

Abscess Oral (abscess in the mouth): 13 people, 86.67%
Osteomyelitis (infection of bone): 13 people, 86.67%
Nuclear Magnetic Resonance Imaging Abnormal: 13 people, 86.67%
Osteosclerosis (an elevation in bone density): 13 people, 86.67%
Metastasis (spreadable cancer to other organ from origin): 13 people, 86.67%
Mastication Disorder (disease of chewing food): 13 people, 86.67%
Malignant Neoplasm Progression (cancer tumour came back): 13 people, 86.67%
Primary Sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone): 13 people, 86.67%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 13 people, 86.67%
Radicular Cyst (a lesser extent dental cyst): 13 people, 86.67%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 80.00%
Breast Cancer: 11 people, 73.33%
Renal Disorder (kidney disease): 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Migraine (headache): 1 person, 6.67%
Immune System Disorder: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%
Diabetes: 1 person, 6.67%
Bone Disorder: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Bone development abnormal?

- Check whether Bone development abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone development abnormal:

Bone development abnormal (76 drugs)

Browse all the conditions that are associated with Bone development abnormal:

Bone development abnormal (124 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.